Company intelligence / Profile preview

Fenix Holding

Pomezia, Lazio, Italy
Ownership
Private
Employees
~60
Development stage
Other
01

Overview

Fenix Pharma is an Italian specialty pharmaceutical company that was acquired by the Spanish healthcare group Uriach in July 2023. Founded in 2011 by a group of experienced pharmaceutical managers, the company specializes in the development and commercialization of products in the fields of urology, gynecology, osteoarticular health, and pediatrics. Its portfolio includes a mix of branded off-patent medicines, medical devices, and high-end nutraceuticals. Fenix Pharma is recognized for its strong commercial presence in the Italian market and its cooperative-based origins, which fostered a lean and efficient business model. The acquisition by Uriach aims to strengthen the group's position in the Italian consumer healthcare market.

Therapeutic areas
CardiovascularRheumatologyNeurologyInfectious Diseases
Modalities
Small moleculeMedical deviceNutraceutical
Industry
Biotech
02

Drug pipeline

1 asset

risedronate sodium

Approved
03

Partnerships

Uriach

Beyond the preview

Go deeper on Fenix Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenix Holding.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call